Schilke Tobin

EDGAR CIK 0001678984

Revance Therapeutics, Inc. - RVNC

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
CFO
Direct Buys
0
$0
0 Shares
Direct Sells
1
($47,204)
-9,361 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/18/2024
03/19/2024
Sell
-9,361 @ $5.04
 ($47,204) 192,666 (-4.63%) Direct